Myxomatous Mitral Valve Disease in Dogs - an Update and Perspectives

Open access


Myxomatous mitral valve disease is a common cause of congestive heart failure in geriatric dogs. Many studies have been done in terms of epidemiology, pathology, associated neurohormonal changes in the disease progression, prognostic factors, and survival and treatment modalities. The presented paper presents a review of some of the studies in the mitral valve disease story.

1. Borgarelli, M., Buchanan, J.W. (2012). Historical review, epidemiology and natural history of degenerative mitral valve disease. J. Vet. Cardiol. 14, 93-101.

2. Buchanan, J. W. (1999). Prevalence of cardiovascular disorders: Prevalence of cardiovascular diseases. In: P. Fox, D. Sisson and S. Moise (Eds). Textbook of Canine and Feline Cardiology. 2nd ed. (pp 457-470). WB Saunders, Philadelphia

3. Olsen, L.H., Fredholm, M., Pedersen, H.D. (1999). Epidemiology and inheritance of mitral valve prolapse in Dachshunds. J. Vet. Intern. Med. 13(5):448-456.

4. Domanjko Petrič, A., Hozjan, E., Blejec, A. (2007). Predisposition and survival of different breeds with chronic valvular disease. Proceedings of 17th European College Veterinary Internal Medicine - Companion Animals Congress, pp. 239, 13th -15th September, Budapest, Hungary.

5. Borgarelli, M., Savarino, P., Crosara, S., Santilli, R.A., Chiavegato, D., Poggi, M., Bellino, C., La Rosa, G., Zanatta, R., Haggstrom, J., Tarducci, A. (2008). Survival characteristics and prognostic variables of dogs with mitral regurgitation attributable to myxomatous valve disease. J. Vet. Intern. Med. 22, 120-128.

6. Garncarz, M., Parzeniecka-Jaworska, M., Jank, M., Łój, M. (2013). A retrospective study of clinical signs and epidemiology of chronic valve disease in a group of 207 Dachshunds in Poland. Acta Vet. Scand. Jul 11, 55:52.

7. Pedersen, H.D, Lorentzen, K.A., Kristensen, B.Ø. (1999). Echocardiographic mitral valve prolapse in Cavalier King Charles Spaniels: epidemiology and prognostic significance for regurgitation. Vet. Rec. 144, 315-320.

8. Serfass, P., Chetboul, V., Sampedrano, C.C., Nicolle, A., Benalloul, T., Laforge, H., Gau, C. Hébert, C., Pouchelon, J.L., Tissier, R. (2006). Retrospective study of 942 small-sized dogs: Prevalence of left apical systolic heart murmur and left-sided heart failure, critical effects of breed and sex. J. Vet. Cardiol., 8(1): 11-18.

9. Hägström, J., Kvart, C., Hansson, K. (1995). Heart sounds and Murmurs: Changes related to severity of chronic valvular disease in the Cavalier King Charles Spaniel. J. Vet. Intern. Med. 9, 75-85.

10. Ohad, D.G. Lenchner, I. Bdolah-Abram, T., Segev, G. (2013). A loud right-apical systolic murmur is associated with the diagnosis of secondary pulmonary arterial hypertension: Retrospective analysis of data from 201 consecutive client-owned dogs (2006-2007). Vet. J. 198, 690-695.

11. Pedersen, H.D. (2000). Mitral valve prolapse in the dog. Pathogenesis, pathophysiology and comparative aspects or early myxomatous mitral valve disease. PhD thesis, Copenhagen

12. Ljungvall, I., Höglund, K., Lilliehöök, I., Oyama, M.A., Tidholm, A., Tvedten, H., Hägström, J. (2013). Serum serotonin concentration is associated with severity of myxomatous mitral valve disease in dogs. J. Vet. Intern. Med. 27, 1105-1112.

13. Detweiler, DK., Patterson, DF. (1965). The prevalence and types of cardiovascular disease in dogs. Ann N Y Acad Sci. Sep 8; 127(1): 481-516.

14. Swenson, L., Hägström, J., Kvart, C., Juneja, R.K. (1996). Relationship between parental cardiac status in Cavalier King Charles Spaniels and prevalence and severity of chronic valvular disease in offspring. J. Amer. Vet. Med. Assoc. 208, 2009-2012.

15. Domanjko Petrič, A., Blagus, R., Mlakar, N. (2013). Survival characteristics in the myxomatous mitral valve disease. Proceedings of the 23rd European College Veterinary Internal Medicine - Companion Animals Congress, September 12-15th, Liverpool

16. Häggström, J., Boswood, A., O’Grady, M., et al. (2008). Effect of pimobendan or benazepril hydrochloride on survival times in dogs with congestive heart failure caused by naturally occurring myxomatous mitral valve disease: the QUEST study. J Vet. Intern. Med. 22(5):1124-1135.

17. Häggström, J., Boswood, A., O’Grady, M., Jöns, O., et al. (2013). Longitudinal analysis of quality of life, clinical, radiographic, echocardiographic, and laboratory variables in dogs with myxomatous mitral valve disease receiving pimobendan or benazepril: the QUEST study. J Vet. Intern. Med. Nov-Dec; 27(6):1441-1451.

18. Rasmussen, C.E., Falk, T., Domanjko Petrič, A., et al. (2014). Holter monitoring of small breed dogs with advanced myxomatous mitral valve disease with and without a history of syncope. J. Vet. Intern. Med. 28(2): 363-370.

19. Dillon, R., Dell’Italia, L. J., Tillson, M., Killingsworth, C., Denney, T., Hathcock, J., Botzman, L. (2012). Left ventricular remodeling in preclinical experimental mitral regurgitation of dogs. J Vet. Cardiol. 14, 1, 73-92.

20. Lord, P., Hansson, K., Kvart, C., Häggström, J. (2010). Rate of change of heart size before congestive heart failure in dogs with mitral regurgitation. J. Small Anim. Pract. 51(4):210-218.

21. Kittleson, M.D. (2005). Myxomatous mitral valve disease. In: Kittleson, M.D. and Kienle R.D. Small Animal Cardiovascular Medicine. defaultadv1.aspx?pid=5928&catId=8440&perlredir=1

22. Reynolds, C.A., Brown, D.C., Rush, J.E., Fox, P.R., Nguyenba, T.P., Lehmkuhl, L.B., Gordon, S.G., Kellihan, H.B., Stepien, R.L, Lefbom, B.K., Meier, C.K.,Oyama, M.A. (2012). Prediction of first onset of congestive heart failure in dogs with degenerative mitral valve disease: The PREDICT cohort study. J. Vet. Cardiol. 14, 1, 193-202.

23. Rishniw, M., Ljungvall, I., Porciello, F., Häggström, J., Ohad, D.G. (2012). Sleeping respiratory rates in apparently healthy adult dogs.Res. Vet. Sci. 93(2):965-9.

24. Bonagura, JD, Schober, KE. (2009). Can ventricular function be assessed by echocardiography in chronic canine mitral valve disease? J Small Anim. Pract. Sep; 50 Suppl. 1, 12-24.

25. Atkins, C., Bonagura, J., Ettinger, S., Fox, P., Gordon, S., Haggstrom, J., Hamlin, R., Keene, B., Luis- Fuentes, V., Stepien, R. (2009). Guidelines for the diagnosis and treatment of canine chronic valvular heart disease. J Vet. Intern. Med. 23(6):1142-50.

26. Atkins, C. E., Häggström, J. (2012). Pharmacologic management of myxomatous mitral valve disease in dogs. J Vet. Cardiol., 14, 1, 165-184.

27. Kvart, C., Häggström, J., Pedersen, HD., Hansson, K., et al. (2002). Efficacy of enalapril for prevention of congestive heart failure in dogs with myxomatous valve disease and asymptomatic mitral regurgitation. J Vet Intern Med. Jan-Feb; 16(1): 80-88.

28. Atkins, C., Keene, B., Brown, W., Coats, J., Crawford, M., et al. (2007). Results of the veterinary enalapril trial to prove reduction in onset of heart failure in dogs chronically treated with enalapril alone for compensated, naturally occurring mitral valve insufficiency. J. Am. Vet. Med. Assoc. 23, 1061-1069.

29. The SOLVD Investigators. (1992). Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. New Eng. J. Med. 327, 725-727.

30. Tarnow, I., Olsen L.H., Kvart, C., Höglund, K., Moesgaard, S.G., Kamstrup, T.S., Pedersen, H.D., Häggström, J. (2009). Predictive value of natriuretic peptides in dogs with mitral valve disease. Vet. J. 180, 195-201.

31. Ljungvall, I., Höglund, K., Carnabuci, C., Tidholm, A., Häggström, J. (2011). Assessment of global and regional left ventricular volume and shape by realtime 3-dimensional echocardiography in dogs with myxomatous mitral valve disease. J. Vet. Intern. Med. 25, 1036-1043.

32. Atkins, J., Bonagura, S., Ettinger, P., Fox, S., Gordon, J., Häggström, R., Hamlin, B., Keene (Chair), V., Luis-Fuentes, Stepien, R. (2009). Guidelines for the diagnosis and treatment of canine chronic valvular heart disease. J. Vet. Intern. Med. 23: 1142-1150.

33. Hezzell, M.J, Boswood, A., Chang, Y.M., Moonarmart, W., Souttar, K., Elliott, J. (2012). The combined prognostic potential of serum highsensitivity cardiac troponin I and N-terminal pro-Btype natriuretic peptide concentrations in dogs with degenerative mitral valve disease. J Vet Intern Med. Mar-Apr; 26(2):302-311.

34. Kanemoto, D., Taguchi, S., Yokoyama, M., Mizuno, H., Suzuki, T Kanamoto (2010). Open heart surgery with deep hypothermia and cardiopulmonary bypass in small and toy dogs. Vet. Surg. 39, 674-679.

35. Yamano, S., Uechi, M., Tanaka, K., Hori, Y., Ebisawa, T., Harada, K., Mizukoshi, T. (2011). Surgical repair of a complete endocardial cushion defect in a dog. Vet. Surg. 40, 408-412.

36. Orton, E.C., Hackett, T.B., Mama, K., Boon, J.A. (2005). Technique and outcome of mitral valve replacement in dogs. J. Am. Vet. Med. Assoc. 226, 1508-1511.

37. Masami Uechi. (2012). Mitral valve repair in dogs. J. Vet. Cardiol. 14, 185-192.

38. Orton, C.E. (2012). Mitral valve degenerations: still more questions than answers. J. Vet. Cardiol. 14, 3-5.

Macedonian Veterinary Review

The Journal of the Faculty of Veterinary Medicine-Skopje at the Ss. Cyril and Methodius University in Skopje

Journal Information

CiteScore 2017: 0.32

SCImago Journal Rank (SJR) 2017: 0.195
Source Normalized Impact per Paper (SNIP) 2017: 0.387


All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 168 168 30
PDF Downloads 43 43 12